Better use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively
Carlos Moreira, IMS Health Managed Markets Service
Advertisement
Articles by Carlos Moreira, IMS Health Managed Markets Service
Advertisement
Latest Updated Articles
- A Data-Driven Approach to Contract Performance Monitoring and Analysis
Published: May 4th 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal
2
Mark Cuban Confirms Cost Plus Drugs Partnership
3
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
4
The Unsung Allies Helping Patients Navigate Specialty Drug Access
5
